CompletedPhase 2NCT03238599

Pedometer Activity Monitoring After ASCT

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Insel Gruppe AG, University Hospital Bern
Principal Investigator
Thomas Pabst, MD
Departement of Medical Oncology, University Hospital Berne
Intervention
Pedometer-based activity monitoring after ASCT(behavioral)
Enrollment
62 enrolled
Eligibility
18-65 years · All sexes
Timeline
20172022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03238599 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials